Published On: Wed, Jul 21st, 2021

J&J Vaccine Significantly Less Effective Against CCP Virus Variants, Study Suggests Save 10% on Citrus trees with code CITRUS
Share This

The Johnson & Johnson vaccine against COVID-19 is significantly less effective against variants, compared to the two other COVID-19 vaccines authorized for use in the United States, a pre-print study by scientists from the New York University School of Medicine suggests. According to the paper’s summary, the antibodies elicited by the two-dose Pfizer–BioNTech and Moderna vaccines “showed modest neutralization resistance against Beta, Delta, Delta plus and Lambda variants.” In contrast, the antibodies generated in response to the single-dose Johnson & Johnson vaccine had “significantly decreased neutralization.” “The data underscore the importance of surveillance for breakthrough infections that result in severe COVID-19 and suggest the benefit of a second immunization following [the Johnson & Johnson vaccine] to increase protection against the variants,” the study states. Johnson & Johnson didn’t immediately respond to a request by The Epoch Times for comment. The company’s chief financial officer, Joseph Wolk, said on CNBC’s “Squawk Box” …

About the Author